Covid vaccine developer Novavax rises 183% ytd on strong phase 3 results

The star holding for the Fund in 2021 thus far is US vaccine producer Novavax which has risen 183% year...

Read More

TESLA: Why we don’t own it

We regularly conclude our quarterly updates with an overview of one of the stocks that we recently added to the...

Read More

Priortech – listed on the TASE – 5% holding in the Fund

As highlighted in previous monthly reports, the two sectors that worked well for us in 2020 were the Renewable Energy...

Read More

Kamada – dually listed on the Nasdaq and on the TASE (ticker KMDA), 3.5% holding in Fund

We wrote about Kamada in March when the company announced its plans to utilise its Hyper-Immunoglobulin (IgG) Platform Technology to...

Read More

Plus500 – listed on the London Stock Exchange (ticker PLUS.L). 3.5% position in the Fund.

Plus500 develops and operates an online trading platform for individual customers to trade contracts for difference (CFDs on approximately 2,800...

Read More

NICE – Dually listed in the TASE and the Nasdaq (ticker NICE). 3% position in the Fund.

NICE is an Israeli based company and the world’s leading provider of both cloud and on-premises enterprise software solutions. Their...

Read More

Radcom – listed on the Nasdaq (ticker RDCM)

RADCOM is a leading expert in cloud-native Network Intelligence for telecom operators transitioning to SDN/NFV (Software Design Networks/Network Functions Virtualization)....

Read More

SolarEdge – listed on the Nasdaq (ticker SEDG)

In January 2018 we wrote about a company called SolarEdge. We described SolarEdge as having a significant technological advantage that,...

Read More

Why we’ve increased our investment in this industry leader

Cerved was founded in 1974 as a data processing centre, and has evolved and grown over the years by innovating...

Read More